Drug
oral micronized progesterone
oral micronized progesterone is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
67%(4 trials)
Phase Distribution
Ph phase_1
1
17%
Ph phase_2
1
17%
Ph phase_4
1
17%
Ph phase_3
3
50%
Phase Distribution
1
Early Stage
1
Mid Stage
4
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
3(50.0%)
Phase 4Post-market surveillance
1(16.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 33 (50.0%)
Phase 41 (16.7%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_3
Oral Micronized Progesterone Effects on Perimenopausal Menstrual Flow
NCT02779582
completedphase_3
Progesterone for Perimenopausal Night Sweats
NCT01464697
completedphase_3
Oral Progesterone for Prevention of Preterm Birth
NCT01180296
completedphase_4
Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality
NCT03720847
completedphase_1
Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women
NCT02272647
Clinical Trials (6)
Showing 6 of 6 trials
NCT02779582Phase 3
Oral Micronized Progesterone Effects on Perimenopausal Menstrual Flow
NCT01464697Phase 3
Progesterone for Perimenopausal Night Sweats
NCT01180296Phase 3
Oral Progesterone for Prevention of Preterm Birth
NCT03720847Phase 4
Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality
NCT02272647Phase 1
Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women
NCT00632099Phase 2
Progesterone Treatment for Cocaine-dependent Women: A Pilot Study
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6